Angelini Pharma acquires Arvelle Therapeutics for $960 million EP News Bureau Jan 4, 2021 Angelini Pharma will have the exclusive license to commercialise cenobamate in the European Union and other countries in the…
FDA approves new treatment for adults with partial-onset seizures EP News Bureau Nov 22, 2019 The safety and efficacy of XCOPRI to treat partial-onset seizures was established in two randomized, double-blind,…
